Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Nurse's call keep gout in check? new trial tests digital support

NCT ID NCT06971146

Disease control Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This Danish trial tests whether nurse-led telehealth support helps people with gout stick to their urate-lowering medication and maintain healthy uric acid levels. 200 adults who have already reached target levels will be randomly assigned to either usual care or a support program where they can choose app reminders, letters, texts, or phone calls from a nurse. The main goal is to see if more people in the support group keep their uric acid under control after one year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nurse-led telehealth support (app, letter, SMS, or phone)
What this could lead to
If it works, this could offer a simple, flexible way to help people with gout stay on track with their medication and avoid flare-ups.
What could go wrong
This is a relatively small, early-stage trial focused on support strategies, not a new drug. The results may not apply to all gout patients or healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥18 years old * Fulfills ACR/EULAR 2015 Gout Classification Criteria * Estimated Glomerular Filtration Rate (e-GFR) \>30 ml/min * Prescribed Allopurinol or Adenuric, and achieved two consecutive serum urate levels of two consecutive serum urate levels of ≤0.30 mmol/l for patients with tophi and ≤0.36 mmol/L for patients without tophi * Have sufficient Danish reading and writing skills to understand information and complete questionnaires. Exclusion Criteria: • Cognitively impaired, unable to understand or provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arthritis, Gouty gout

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence Digital health Gout arthritis Gout initiating urate-loweringurate-lowering therapy Health literacy Telehealth

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aarhus University Hospital

    RECRUITING

    Aarhus, 8200, Denmark

  • Gødstrup Hospital

    RECRUITING

    Herning, 7400, Denmark

  • Horsens Hospital

    RECRUITING

    Horsens, 8700, Denmark

  • Randers Hospital

    RECRUITING

    Randers, 8930, Denmark

  • Silkeborg Hospital

    RECRUITING

    Silkeborg, 8600, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.